Short answer · Medically reviewed summary · Last updated: 2026-05-08
Primary Sclerosing Cholangitis (PSC) is classified under ICD-10 code K83.01 for primary sclerosing cholangitis and ICD-9 code 576.1 for cholangitis. These medical billing codes are essential for healthcare providers and insurers to identify Primary Sclerosing Cholangitis within the digestive and immune system frameworks. What is the clinical significance of Primary Sclerosing Cholangitis coding? Accurate coding for Primary Sclerosing Cholangitis ensures that patients receive appropriate insurance coverage for specialized care, such as hepatology consultations and liver transplants.
ICD10 code of Primary Sclerosing Cholangitis and ICD9 code
ICD-10 and ICD-9 codes for Primary Sclerosing Cholangitis, with classification details for clinicians, coders and patients.
Primary Sclerosing Cholangitis (PSC) is classified under ICD-10 code K83.01 for primary sclerosing cholangitis and ICD-9 code 576.1 for cholangitis. These medical billing codes are essential for healthcare providers and insurers to identify Primary Sclerosing Cholangitis within the digestive and immune system frameworks.
What is the clinical significance of Primary Sclerosing Cholangitis coding?
Accurate coding for Primary Sclerosing Cholangitis ensures that patients receive appropriate insurance coverage for specialized care, such as hepatology consultations and liver transplants. Because Primary Sclerosing Cholangitis is a complex, chronic condition affecting the bile ducts, precise documentation is vital for tracking disease progression and managing systemic symptoms like jaundice, intense itching, and fatigue.
What are the primary symptoms and current management approaches for Primary Sclerosing Cholangitis?
Patients with Primary Sclerosing Cholangitis often experience a combination of systemic and digestive distress. Clinical management focuses on alleviating symptoms and monitoring liver function to prevent complications. Current treatment modalities include:
- Pharmacotherapy: Use of Ursodiol to improve bile flow and Vancomycin for potential modulation of the gut-liver axis.
- Symptom Control: Administration of Cholestrim (cholestyramine) powder to manage intractable pruritus (itching).
- Surgical Intervention: Liver transplantation remains the only definitive therapy for end-stage Primary Sclerosing Cholangitis.
- Supportive Care: Managing nutritional status to combat weight loss and monitoring for enlarged liver (hepatomegaly) or spleen (splenomegaly).
How does the DiseaseMaps community support those with Primary Sclerosing Cholangitis?
Living with a rare disease can feel isolating. At DiseaseMaps.org, 36 people with Primary Sclerosing Cholangitis have joined the community to share their personal experiences, symptom management tips, and emotional support. Connecting with others who understand the burden of Primary Sclerosing Cholangitis can significantly improve quality of life and provide practical insights into navigating the healthcare system.
Next steps
- Consult with a board-certified hepatologist to review your specific ICD-10 coding and care plan.
- Join the 36 members at DiseaseMaps.org to find peer support and share experiences with Primary Sclerosing Cholangitis.
- Keep a detailed symptom diary to help your care team track the progression of your Primary Sclerosing Cholangitis.
Medical disclaimer: This information is for educational purposes only and does not constitute professional medical advice, diagnosis, or treatment; always seek the advice of your physician or other qualified health provider with any questions regarding a medical condition.
References
- NIH Genetic and Rare Diseases Information Center (GARD): Primary Sclerosing Cholangitis Overview.
- Orphanet: Rare Disease Database (ORPHA: 184).
- OMIM (Online Mendelian Inheritance in Man): Entry #600837.
- World Health Organization (WHO): ICD-10 and ICD-11 coding classifications for hepatobiliary diseases.
